Overview
Marc Hirsh is a Hematologist Oncology provider in Hanover, Pennsylvania. Dr. Hirsh is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Paget Disease of the Breast.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
Locations
Upper Chesapeake Hematology And Oncology Services, LLC
Myo Min is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Min is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Colorectal Cancer, and Large-Cell Immunoblastic Lymphoma. Dr. Min is currently accepting new patients.
University Of Maryland St Joseph Medical Group LLC
Richard Schraeder is a Hematologist Oncology specialist and a Hematologist in Towson, Maryland. Dr. Schraeder is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Retroperitoneal Liposarcoma. Dr. Schraeder is currently accepting new patients.
Medstar Medical Group Ii LLC
Mahsa Mohebtash is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Mohebtash is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Mohebtash is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Hirsh isDistinguished. Learn about Lung Cancer.
- Paget Disease of the BreastDr. Hirsh isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Hirsh isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Hirsh isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Breast CancerDr. Hirsh isAdvanced. Learn about Breast Cancer.
- Cervical CancerDr. Hirsh isAdvanced. Learn about Cervical Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Hirsh isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)
- EGFR Positive Lung CancerDr. Hirsh isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Acute Mountain SicknessDr. Hirsh isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Hirsh isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Hirsh isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Hirsh isExperienced. Learn about Agranulocytosis.